Found: 2
Select item for more details and to access through your institution.
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response--a prospective, single-arm study.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1169666
- By:
- Publication type:
- Article
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 117, doi. 10.3390/vaccines11010117
- By:
- Publication type:
- Article